Evidence map›Paper›PMID 31883511›Full record

ArticleBMC neuroscience2019

The Bdnf and Npas4 genes are targets of HDAC3-mediated transcriptional repression.

Anto Sam Crosslee Louis Sam Titus, Dharmendra Sharma, Min Soo Kim, Santosh R D'Mello

Open access · goldAbstract read
In one paragraph

Article in BMC neuroscience, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Amyloid β-Oligomers Inhibit the Nuclear CaAntioxidants (Basel, Switzerland) · 2023
    Article
  7. Article
  8. Article
  9. Histone deacetylase-3: Friend and foe of the brain.Experimental biology and medicine (Maywood, N.J.) · 2020
    Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Anto Sam Crosslee Louis Sam TitusDepartment of Biological Sciences, Southern Methodist University, Dallas, TX, USA.
Dharmendra SharmaDepartment of Biological Sciences, Southern Methodist University, Dallas, TX, USA.
Min Soo KimQuantitative Biomedical Research Center, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Santosh R D'MelloDepartment of Biological Sciences, Southern Methodist University, Dallas, TX, USA. dmello@utdallas.edu.ORCID 0000-0002-7652-1334
Southern Methodist University · USThe University of Texas Southwestern Medical Center · US

Funding

Signaling Pathways Regulating Neuronal SurvivalR01NS040408 · NINDS · UNIVERSITY OF TEXAS DALLAS · PI D'MELLO, SANTOSH R · 2002 to 2018
$4.8M
NIH HHS R01 NS040408NINDS NIH HHS R01 NS040408
6 · The paper itself

Abstract

backgroundHistone deacetylase-3 (HDAC3) promotes neurodegeneration in various cell culture and in vivo models of neurodegeneration but the mechanism by which HDAC3 exerts neurotoxicity is not known. HDAC3 is known to be a transcriptional co-repressor. The goal of this study was to identify transcriptional targets of HDAC3 in an attempt to understand how it promotes neurodegeneration.

resultsWe used chromatin immunoprecipitation analysis coupled with deep sequencing (ChIP-Seq) to identify potential targets of HDAC3 in cerebellar granule neurons. One of the genes identified was the activity-dependent and neuroprotective transcription factor, Neuronal PAS Domain Protein 4 (Npas4). We confirmed using ChIP that in healthy neurons HDAC3 associates weakly with the Npas4 promoter, however, this association is robustly increased in neurons primed to die. We find that HDAC3 also associates differentially with the brain-derived neurotrophic factor (Bdnf) gene promoter, with higher association in dying neurons. In contrast, association of HDAC3 with the promoters of other neuroprotective genes, including those encoding c-Fos, FoxP1 and Stat3, was barely detectable in both healthy and dying neurons. Overexpression of HDAC3 leads to a suppression of Npas4 and Bdnf expression in cortical neurons and treatment with RGFP966, a chemical inhibitor of HDAC3, resulted in upregulation of their expression. Expression of HDAC3 also repressed Npas4 and Bdnf promoter activity.

conclusionOur results suggest that Bdnf and Npas4 are transcriptional targets of Hdac3-mediated repression. HDAC3 inhibitors have been shown to protect against behavioral deficits and neuronal loss in mouse models of neurodegeneration and it is possible that these inhibitors work by upregulating neuroprotective genes like Bdnf and Npas4.

Indexed as

AcrylamidesAnimalsBasic Helix-Loop-Helix ProteinsBrain-Derived Neurotrophic FactorCells, CulturedCerebellumForkhead Transcription FactorsGene Expression RegulationHistone Deacetylase 3Histone Deacetylase InhibitorsHistone DeacetylasesNeuronsPhenylenediaminesPromoter Regions, GeneticProto-Oncogene Proteins c-fosRats, WistarAcrylamidesBasic Helix-Loop-Helix ProteinsBdnf protein, ratBrain-Derived Neurotrophic FactorForkhead Transcription FactorsFoxP1 protein, ratHistone Deacetylase 3Histone Deacetylase InhibitorsHistone DeacetylasesNpas4 protein, ratPhenylenediaminesProto-Oncogene Proteins c-fosRepressor ProteinsRGFP966Stat3 protein, ratSTAT3 Transcription FactorBdnfChIP-SeqHDAC3NeurodegenerationNeurotoxicNpas4

Identifiers

PMID31883511
PMCPMC6935488
OpenAlexW2997146877

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.